G0S2 and glioma: Further, mRNA expression of G0S2 was higher in recurrent malignant glioma, diagnosed as WHO grade IV secondary GBM, than in initial glioma, diagnosed as WHO grade II diffuse astrocytoma, within the same patient (Fig 2B).